Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
10X Genomics | 4,695 | 2023q3 | |||||||||
Abbott Laboratories | 201,775 | 2023q2 | |||||||||
Accolade, Inc. (Pennsylva... | 296 | 2022q3 | |||||||||
Accuray | 245 | 2024q2 | |||||||||
Addus HomeCare | 2,165 | 2023q1 | |||||||||
AirSculpt Technologies | 258 | 2023q3 | |||||||||
Alcon | 42,614 | 2022 | |||||||||
Align Technology | 15,122 | 2023q3 | |||||||||
Amedisys | 3,194 | 2024q2 | |||||||||
American Well | 339 | 2023q3 | |||||||||
AptarGroup | 8,119 | 2023q3 | |||||||||
Asensus Surgical (TransEn... | 66 | 2023q3 | |||||||||
AtriCure | 1,185 | 2022 | |||||||||
Avanos Medical | 864 | 2023 | |||||||||
Avantor | 15,280 | 2023q3 | |||||||||
AxoGen | 622 | 2023q3 | |||||||||
Baxter International | 21,298 | 2023 | |||||||||
Becton, Dickinson and Co | 70,015 | 2024q1 | |||||||||
Bellerophon Therapeutics | 0 | 2021 | |||||||||
BioLife Solutions | 1,151 | 2023q3 |